Dr. Abraham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9427 SW Barnes Road
Suite 498
Portland, OR 97225Phone+1 503-216-0900Fax+1 503-216-0950
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2004 - 2008- Johns Hopkins UniversityResidency, Internal Medicine, 2001 - 2004
- Johns Hopkins University School of MedicineClass of 2001
Certifications & Licensure
OR State Medical License 2009 - 2025
WA State Medical License 2009 - 2012
MD State Medical License 2005 - 2010- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Telemedicine Technology Demonstration Project for Heart Failure Start of enrollment: 2014 Mar 23
- Cardiogenic Shock Working Group Registry Start of enrollment: 2017 Dec 04
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsFactors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group.Ajar Kochar, Saraschandra Vallabhajosyula, Kevin John, Shashank S Sinha, Michele Esposito
The Journal of Heart and Lung Transplantation. 2024-11-01 - 1 citationsPrognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock.Saraschandra Vallabhajosyula, Anthony J Faugno, Borui Li, Kevin John, Qiuyue Kong
Journal of Cardiac Failure. 2024-11-01 - Body Mass Index and Mortality in Cardiogenic Shock.Maya Guglin, Elric Zweck, Manreet Kanwar, Shashank S Sinha, Arvind Bhimaraj
ASAIO Journal. 2024-10-01
Press Mentions
After Rare and Serious Complication From COVID-19, Oregon Mom Is Back in Good HealthApril 14th, 2023
Hemodynamic Monitoring Benefit Affirmed for Seniors with HFMay 15th, 2019
FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or CardiomyopathyMay 13th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
